17 November 2022
During this 50-minute panel discussion at Pharma Integrates 2022, tranScrip's Head of Scientific Affairs and Oncology, Linda Summerton joined other heathcare professionals to discuss how advances in prevention, early detection, diagnosis and treatments are improving patient outcomes, but there is still a lot more to do.
Linda Summerton | Head of Scientific Affairs and Oncology | tranScrip
Jason Mellad | CEO and Co-Founder | Start Codon
Marcel Gehrung | CEO & Co-founder | Cyted
Renata Crome | Trustee, Non Executive Director and Pharmaceutical Development Advisor | PTEN Research Foundation
Emma Kinloch | Founder | Salivary Gland Cancer UK
Jane Robertson | Chief Medical Officer | Redx Pharma